Feed GLPG.AS
GL
Lakefront Biotherapeutics
GLPG.AS · AMS
26.28 € +2.26% (+0.58 €)
1M -16.12%
Market Cap 1.7B €
P/E Ratio -
Div. Yield -
ROE 15.62%
Bulios Fair Price
35.8 €
36.2% upside
Current Price
26.28 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GLPG.AS is currently undervalued relative to its market price. How does it work?
Valuation
75 /100
Cheap P/S 6.04x
P/B 0.60x
PEG 0.02x
Growth
7 /100
Declining Rev. growth 20.55%
Book val. growth 1.54%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 181.21%
Net margin 151.94%
FCF margin 100.14%
Quality
1 /100
Poor ROIC 13.60%
ROE 15.62%
Asset turnover 0.07x
Debt
80 /100
Low Debt/Equity 0.00x
Current ratio 8.63x
Net debt/EBITDA 0.16x
Stability
28 /100
Unstable Beta -0.20x
Rev. volatility 32.00%
Profitable years 3
Ask StockBot about GLPG.AS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Henry O. Gosebruch
Employees
452
Headquarters
Mechelen
Upcoming events
10 AUG
Earnings
Upcoming earnings report